RK MedCenter SRL
- Address
- lock Available on a paid plan
RK MedCenter SRL - Rheumatology and Autoimmune Disease Research
RK MedCenter SRL is a clinical research facility specializing in rheumatological disorders and autoimmune conditions. The center focuses on advancing therapeutic options for patients with chronic inflammatory diseases, particularly those affecting joints and connective tissues.
- Psoriatic arthritis treatment development and biologic therapy research
- Novel disease-modifying anti-rheumatic drug (DMARD) evaluation
- Autoimmune disease management in biologic-naïve patient populations
The research center demonstrates expertise in evaluating innovative therapies for active psoriatic arthritis, with particular emphasis on studying new treatment modalities in patients who have not previously received biologic disease-modifying anti-rheumatic drugs. This focus positions RK MedCenter SRL at the forefront of discovering safer and more effective therapeutic options for managing chronic inflammatory arthritis conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Dr Reddy's Laboratories Limited1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in RK MedCenter SRL
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-1) | Bristol-Myers Squibb Services Unlimited Company | Phase III | Not Recruiting | May 2023 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Deucravacitinib | 2 | Unknown | 2021-10-20 | 2023-05-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.